Resumen de A New Treatment for Metastatic Breast Cancer

Diane S. Aschenbrenner

• * A new treatment is now available for postmenopausal women with estrogen receptor–positive, human epidermal growth factor receptor 2–negative metastatic breast cancer. Palbociclib (Ibrance) inhibits cyclin-dependent kinases 4 and 6.